Image

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Recruiting
18-65 years
All
Phase 1

Powered by AI

Overview

The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.

Eligibility

Inclusion Criteria:

  1. Persons with severe sciatic nerve injury, brachial plexus injury, and/or major nerve injury at the upper or lower extremity within previous year;
  2. Between the ages of 18 and 65 at last birthday

Exclusion Criteria:

  1. Persons unable to safely undergo an MRI;
  2. Persons with pre-existing conditions that would preclude satisfactory sural nerve harvest;
  3. Persons with severe peripheral nerve injury gap length > 10 cm;
  4. Persons with history of radiation or local cancer in area of nerve injury, including primary tumors of the nerve;
  5. Pregnant women or a positive pregnancy test in those women with reproductive potential prior to enrollment;
  6. Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study;
  7. History of active substance abuse;
  8. Persons allergic to gentamicin;
  9. Persons who test positive for HIV or Hepatitis B or C virus.
  10. Persons unable to provide consent independently due to cognitive impairment

Study details
    Peripheral Nerve Injury

NCT05541250

W. Dalton Dietrich

3 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.